Actively Recruiting
Focal Cryoballoon Ablation for Malignant Dysphagia
Led by Laura Boer · Updated on 2024-10-01
20
Participants Needed
1
Research Sites
79 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Rationale: Dysphagia is commonly encountered in patients with esophageal carcinoma who are no candidates for treatment with curative intent. It often has a considerable impact on quality of life and can cause malnourishment. Current palliative treatments mainly include esophageal stenting and radiotherapy, but these can be associated with substantial drawbacks such as a high rate of adverse events, fatigue or an untimely/ temporary symptom improvement. Recent studies showed promising results for the use of spray cryotherapy as palliation for dysphagia. Moreover, there are suggestions that cryotherapy has a positive effect on the host's anti-tumor response. However, no data exists on the feasibility, efficacy and safety for cryoballoon therapy in the esophagus. Secondly, cryo-immunologic data in patients with EC is lacking. Objective: 1. To evaluate the feasibility of cryoballoon ablation in patients with esophageal carcinoma and symptoms of dysphagia. Additionally, efficacy and safety will be assessed. 2. To evaluate the effect of cryoballoon ablation on host's anti-tumor response. Study design: Pilot study, Multi-center Prospective Uncontrolled Intervention Study Study population: Adult patients (≥18 years) with dysphagia due to incurable esophageal carcinoma Intervention (if applicable): Focal cryoballoon ablation of visible tumor during an upper endoscopy. Cryoballoon ablation will be performed for two cycles of 12 seconds. In total, patients will undergo 3 treatment sessions (range 1-3) with an interval of 1-3 weeks based onthe severity of symptoms reported by the patient. Main study parameters/endpoints: * \- Feasibility of cryoballoon ablation defined as technical success of the procedure * Safety based on incidence of procedure-related serious adverse events * Efficacy defined as success rates two weeks after the last cryoablation treatment based on patient reported symptom improvement, and objective evaluation of the esophageal lumen that is free from tumor * Host's anti-tumor response after cryoballoon ablation based on sequential esophageal tumor biopsies and peripheral blood samples
CONDITIONS
Official Title
Focal Cryoballoon Ablation for Malignant Dysphagia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age greater than 18 years at time of consent
- Histopathologically-confirmed esophageal or gastroesophageal cancer
- Patients receiving palliative care with or without systemic chemotherapy
- Dysphagia score of 2 or higher (able to swallow only semi-solids)
- Signed written informed consent
You will not qualify if you...
- Dysphagia caused by reasons other than esophageal cancer
- Unable to pass the ultraslim endoscope
- Severe medical conditions preventing endoscopy
- Uncorrected blood clotting problems
- Prior distal esophagectomy surgery
- Previous esophageal varices
- Expected survival less than 6 weeks
- Prior radiotherapy for esophageal cancer
- T4b stage esophageal cancer
- Incapacitated individuals
- Pregnant or breastfeeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UMCU
Utrecht, Netherlands
Actively Recruiting
Research Team
L
Laura S Boer, Degree of medicine
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here